JPWO2019230857A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019230857A5
JPWO2019230857A5 JP2020522576A JP2020522576A JPWO2019230857A5 JP WO2019230857 A5 JPWO2019230857 A5 JP WO2019230857A5 JP 2020522576 A JP2020522576 A JP 2020522576A JP 2020522576 A JP2020522576 A JP 2020522576A JP WO2019230857 A5 JPWO2019230857 A5 JP WO2019230857A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
alkyl
ring
aromatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020522576A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019230857A1 (ja
JP7353707B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/021445 external-priority patent/WO2019230857A1/ja
Publication of JPWO2019230857A1 publication Critical patent/JPWO2019230857A1/ja
Publication of JPWO2019230857A5 publication Critical patent/JPWO2019230857A5/ja
Application granted granted Critical
Publication of JP7353707B2 publication Critical patent/JP7353707B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020522576A 2018-05-31 2019-05-30 多環性ピリドン誘導体 Active JP7353707B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018104160 2018-05-31
JP2018104160 2018-05-31
PCT/JP2019/021445 WO2019230857A1 (ja) 2018-05-31 2019-05-30 多環性ピリドン誘導体

Publications (3)

Publication Number Publication Date
JPWO2019230857A1 JPWO2019230857A1 (ja) 2021-06-24
JPWO2019230857A5 true JPWO2019230857A5 (https=) 2022-05-23
JP7353707B2 JP7353707B2 (ja) 2023-10-02

Family

ID=68698906

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020522576A Active JP7353707B2 (ja) 2018-05-31 2019-05-30 多環性ピリドン誘導体

Country Status (22)

Country Link
US (1) US11453669B2 (https=)
EP (1) EP3805221A4 (https=)
JP (1) JP7353707B2 (https=)
KR (1) KR102770090B1 (https=)
CN (1) CN112533922B (https=)
AU (1) AU2019277547B2 (https=)
BR (1) BR112020024098A2 (https=)
CA (1) CA3101950A1 (https=)
CL (1) CL2020002987A1 (https=)
CO (1) CO2020014296A2 (https=)
CR (1) CR20200645A (https=)
DO (1) DOP2020000222A (https=)
EA (1) EA202092923A1 (https=)
IL (1) IL279050B2 (https=)
MA (1) MA52802A (https=)
MX (1) MX2020012185A (https=)
MY (1) MY203593A (https=)
PE (1) PE20201414A1 (https=)
PH (1) PH12020551999A1 (https=)
SG (1) SG11202011386QA (https=)
WO (1) WO2019230857A1 (https=)
ZA (1) ZA202007568B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4257137A3 (en) 2018-05-31 2023-11-01 Shionogi & Co., Ltd Polycyclic carbamoylpyridone derivatives for the treatment of hiv
MY201239A (en) 2019-03-22 2024-02-13 Gilead Sciences Inc Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
WO2021107065A1 (ja) * 2019-11-28 2021-06-03 塩野義製薬株式会社 多環性ピリドピラジン誘導体
EP4066839A4 (en) * 2019-11-28 2023-12-27 Shionogi & Co., Ltd PROPHYLACTIC AND THERAPEUTIC MEDICINAL PRODUCT FOR HIV INFECTIOUS DISEASES, CHARACTERIZED BY CONTAINING THE COMBINATION OF INTEGRAS INHIBITORS AND ANTI-HIV AGENTS
JP2021091671A (ja) * 2019-11-28 2021-06-17 塩野義製薬株式会社 多環性ピリドン誘導体を含有する医薬組成物
PE20221569A1 (es) 2020-02-24 2022-10-06 Gilead Sciences Inc Compuestos tetraciclicos para el tratamiento de infecciones por vih
JP7407976B2 (ja) * 2020-05-21 2024-01-04 シーセン ファーマシューティカル カンパニー リミテッド 縮合環誘導体及びその薬学的用途
US20240018145A1 (en) * 2020-07-27 2024-01-18 Merck Sharp & Dohme Llc Polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenza
ES3064867T3 (en) 2020-09-30 2026-04-29 Gilead Sciences Inc Bridged tricyclic carbamoylpyridone compounds for a use in the treatment of hiv
US11613546B2 (en) 2021-01-19 2023-03-28 Gilead Sciences, Inc. Substituted pyridotriazine compounds and uses thereof
EP4384178A4 (en) * 2021-08-11 2025-07-02 Merck Sharp & Dohme Llc POLYCYCLIC CAP-DEPENDENT ENDONUCLEASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF INFLUENZA
TW202446773A (zh) 2022-04-06 2024-12-01 美商基利科學股份有限公司 橋聯三環胺甲醯基吡啶酮化合物及其用途

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2498111A1 (en) 2002-09-11 2004-03-25 Merck & Co., Inc. Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
NZ540729A (en) 2002-12-27 2008-03-28 Angeletti P Ist Richerche Bio Tetrahydro-4H-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors
TW200510425A (en) 2003-08-13 2005-03-16 Japan Tobacco Inc Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
ATE516026T1 (de) 2005-02-21 2011-07-15 Shionogi & Co Bicyclisches carbamoylpyridonderivat mit hiv- integrase-hemmender wirkung
KR101363875B1 (ko) 2005-04-28 2014-02-21 시오노기세야쿠 가부시키가이샤 Hiv 통합효소 억제 활성을 가지는 다환식카르바모일피리돈 유도체
MX2008005137A (es) 2005-10-27 2008-09-29 Shionogi & Co Derivado de carbamoilpiridona policiclica que tiene actividad inhibidora en vih integrasa.
CA2789457A1 (en) 2010-02-26 2011-09-01 Susumu Miyazaki 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor
US9216995B2 (en) 2010-04-12 2015-12-22 Shionogi & Co., Ltd. Pyridone derivative having integrase inhibitory activity
RU2014113230A (ru) * 2011-10-12 2015-11-20 Шионоги Энд Ко., Лтд. Полициклическое производное пиридона, обладающее ингибирующей активностью в отношении интегразы
EP2931730B1 (en) 2012-12-17 2019-08-07 Merck Sharp & Dohme Corp. 4-pyridinonetriazine derivatives as hiv integrase inhibitors
EA030003B1 (ru) 2012-12-21 2018-06-29 Джилид Сайэнс, Инк. Полициклическое карбамоилпиридоновое соединение и его фармацевтическое применение для лечения вич-инфекции
PE20151063A1 (es) 2012-12-27 2015-08-03 Japan Tobacco Inc DERIVADO SUSTITUIDO DE ESPIROPIRIDO[1,2-a]PIRAZINA Y USO MEDICO DEL MISMO COMO INHIBIDOR DE LA INTEGRASA DEL VIH
RS56701B1 (sr) 2013-05-17 2018-03-30 Merck Sharp & Dohme Fuzionisana triciklična heterociklična jedinjenja kao inhibitori hiv integraze
EP3008044B1 (en) 2013-06-13 2018-11-21 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
WO2014200080A1 (ja) 2013-06-14 2014-12-18 ヤンマー株式会社 予測装置、予測方法及びコンピュータプログラム
NO2865735T3 (https=) 2013-07-12 2018-07-21
ES2859102T3 (es) 2013-07-12 2021-10-01 Gilead Sciences Inc Compuestos de carbamoilpiridona policíclica y su uso para el tratamiento de infecciones por VIH
WO2015039348A1 (en) 2013-09-23 2015-03-26 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
UA117499C2 (uk) 2013-09-27 2018-08-10 Мерк Шарп Енд Доум Корп. Заміщені похідні хінолізину, які можна використовувати як інгібітори інтегрази віл
WO2015089847A1 (en) 2013-12-20 2015-06-25 Merck Sharp & Dohme Corp. Spirocyclic heterocycle compounds useful as hiv integrase inhibitors
WO2015199167A1 (ja) 2014-06-25 2015-12-30 日本たばこ産業株式会社 置換されたスピロピリド[1,2-a]ピラジン誘導体の製造方法および中間体
JPWO2016027879A1 (ja) 2014-08-22 2017-06-01 塩野義製薬株式会社 インテグラーゼ阻害活性を有する多環性ピリドン誘導体
WO2016090545A1 (en) 2014-12-09 2016-06-16 Merck Sharp & Dohme Corp. Spirocyclic heterocycle compounds useful as hiv integrate inhibitors
US10150780B2 (en) 2014-12-09 2018-12-11 Merck Sharp & Dohme Corp. Spirocyclic heterocycle compounds useful as HIV integrase inhibitors
TWI695003B (zh) 2014-12-23 2020-06-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
WO2016154527A1 (en) 2015-03-26 2016-09-29 Merck Sharp & Dohme Corp. Phosphate-substituted quinolizine derivatives useful as hiv integrase inhibitors
KR20190057158A (ko) 2015-04-02 2019-05-27 길리애드 사이언시즈, 인코포레이티드 폴리시클릭-카르바모일피리돈 화합물 및 그의 제약 용도
WO2016187788A1 (en) 2015-05-25 2016-12-01 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds useful for treating hiv infection
US10624912B2 (en) 2015-11-17 2020-04-21 Merck Sharp & Dohme Corp. Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors
US10548910B2 (en) 2015-11-17 2020-02-04 Merck Sharp & Dohme Corp. Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors
US10544155B2 (en) 2015-12-15 2020-01-28 Merck Sharp & Dohme Corp. Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors
WO2017113288A1 (en) 2015-12-31 2017-07-06 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
JOP20190130A1 (ar) 2016-12-02 2019-06-02 Merck Sharp & Dohme مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv)
CA3042314A1 (en) 2016-12-02 2018-06-07 Merck Sharp & Dohme Corp. Tricyclic heterocycle compounds useful as hiv integrase inhibitors
EP3752144B1 (en) 2018-02-15 2022-12-28 Merck Sharp & Dohme LLC Tricyclic heterocycle compounds useful as hiv integrase inhibitors
KR20210005139A (ko) 2018-04-27 2021-01-13 머크 샤프 앤드 돔 코포레이션 Hiv 인테그라제 억제제로서 유용한 트리시클릭 헤테로사이클 화합물
CN110526930B (zh) 2018-05-23 2022-06-03 莫云芬 抗hiv病毒的含硫多环-羟基吡啶酮甲酰胺类似物及其应用
EP3801543B1 (en) 2018-06-05 2024-09-11 Merck Sharp & Dohme LLC Tricyclic heterocycle compounds useful as hiv integrase inhibitors
MY201239A (en) 2019-03-22 2024-02-13 Gilead Sciences Inc Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use

Similar Documents

Publication Publication Date Title
JPWO2019230857A5 (https=)
JPWO2019230858A5 (https=)
US12268086B2 (en) Compound for organic electric element, organic electric element comprising the same and electronic device thereof
JP2021091671A5 (https=)
EA202092923A1 (ru) Полициклическое производное пиридона
ES2555491T3 (es) Composiciones y métodos para la inhibición de la ruta de JAK
ECSP24026637A (es) Derivados de 3-(5-hidroxi-1-oxoisoindolin-2-il)piperidina-2,6-diona
JP2019135229A5 (https=)
Song et al. Diversity-oriented synthesis and antifungal activities of novel pimprinine derivative bearing a 1, 3, 4-oxadiazole-5-thioether moiety
JP2016536364A5 (https=)
Baran et al. A remarkable ring contraction en route to the chartelline alkaloids
AR076830A1 (es) Compuestos de carboxamidas de imidazol como moduladores de trpv3
PE20201068A1 (es) Compuestos de pirazol sustituidos con heteroarilo y uso farmaceutico de los mismos
ES2422603T3 (es) Compuestos oxiimino y el uso de estos
CY1114508T1 (el) Βιολογικα δραστικες ενωσεις οι οποιες ειναι δυνατον να λαμβανονται απο sorangium cellulosum
Karthikeyan et al. Diastereoselective syntheses of pyrazolyl isoxazolidines via 1, 3-dipolar cycloaddition
Arab‐Salmanabadi Synthesis and Spectral Characterization of Novel Bis‐thiazole Derivatives via Ring Closure of Benzo [d] thiazol‐2‐amine, Various α‐Haloketones, and S‐Nucleophiles
Er et al. Synthesis and characterization of novel 1, 3-thiazole and 2-amino-1, 3, 4-thiadiazole derivatives
Hassan et al. Synthesis of (E)-2, 5-disubstituted 1, 3, 4-thiadiazolyl-2, 3-diphenylpropenones from alkenylidene-hydrazinecarbothioamides
IL275434A (en) Method for producing thiocarboxamidine salt compound
Hassan et al. Reactions of dimethyl ethynedicarboxylate with (substituted ethylidene) hydrazinecarbothioamides
WO2007123732A3 (en) Antifungal and antiparasitic indoloquinoline derivatives
Dunstan et al. Dipolar cycloaddition reactions of nitrilimines
US4412079A (en) Thiadiazole compounds and methods of using said compounds in agriculture
UY40670A (es) Compuestos y su uso en el tratamiento del cáncer